Buy now, pay later available. Select ClearPay during checkout.

Cart (0)
English en
  • English en
  • Polski pl

ProbioBALANCE, Lactobacillus Rhamnosus GG Balance 5 billion, 30 vegan probiotic capsules, Aliness


Regular price £10.39

Tax included.
  • ProbioBalance by Aliness®
  • Rhamnosus GG Balance
  • 30 Vege capsules
  • Diet supplement
  • Maintaining the proper functioning of the intestines


1 capsule

2 capsules (daily dose)

Prebiotic - Fibregum ™ Bio LAW polysaccharide

100 mg

200 mg

Plantain - Extract (Plantago Lanceolata)

20 mg

40 mg


5 * 109 cells

10 * 109 cells

Lactobacillus rhamnosus GG

5 * 109 cells

10 * 109 cells

(1 * 109 cells = 1 billion)

Ingredients: Prebiotic - Fibregum ™ Bio LAW Polysaccharide (aw <0.2%), Plantain - extract (Plantago Lanceolata), Lactobacillus rhamnosus GG ATCC 53103, bacteria shell: glycerin esters of fatty acids, capsule shell (hydroxypropyl methylcellulose).

* Plantain helps to maintain normal bowel function

ProbioBalance by Aliness® Rhamnosus GG Balance has only one strain of Lactobacillus rhamnosus GG bacteria.

Recommended daily intake required to obtain the beneficial effects of the product: 1-2 capsules daily with a meal.

Do not exceed recommended servings for consumption during the day. The dietary supplement cannot be used as a substitute for a varied diet. A balanced diet and a healthy lifestyle are the basis for the proper functioning of the body.

Dietary supplement ProbioBalance by Aliness® Rhamnosus GG Balance contains 5 billion bacteria in each capsule. Each bacterium has been coated with a double lipid layer providing an effective barrier and allowing the bacteria to safely pass through the acidic environment of the stomach to reach the intestines intact, where it is to exhibit its biological activity.

Storage conditions: The product can be stored under room conditions.

Cooling will extend the shelf life. Temperatures above 25 ° C should be avoided.

Store out of reach of small children.

In order to ensure the highest quality of the product throughout its expiry date, a 20% technological allowance is added at the production stage, i.e. approx. 20% more bacteria to each capsule.

** The use of microencapsulated lactic acid bacteria requires a specific, patented method of analysis, available from the manufacturer, for the quantification of viable bacterial cells (flow cytometry). Patent no RM2009A000591


Konrad Malitka

Ostrówiec 150

05-480 Karczew, Poland

Open drop down